« Previous
Next »
Titles
- DSCSA standards for the interoperable exchange of information for tracing of certain human, finished, prescription drugs: guidance for industry1
- Defense health care: DOD assessment needed to ensure TRICARE behavioral health coverage goals are being met : report to congressional committees1
- Designing Medi-Cal consumer advisory committees: insights from a survey of Medi-Cal managed care plans1
- Development and licensure of vaccines to prevent COVID-19: guidance for industry1
- Development of monoclonal antibody products targeting SARS-CoV-2 for emergency use authorization: guidance for industry1
- Did disparities in access worsen during the pandemic?: comparing Californians with Medi-Cal and those with employer coverage1
- Digital health technologies for remote data acquisition in clinical investigations: guidance for industry, investigators, and other stakeholders1
- Direct-to-consumer prescription drug advertisements: presentation of the major statement in a clear, conspicuous, and neutral manner in advertisements in television and radio format final rule : questions and answers : guidance for industry1
- Disaggregating race and ethnicity data: findings from community focus groups1
- Disparities in Minnesota’s COVID-19 vaccination rates1
- Do No Harm guide. Collecting, analyzing, and reporting gender and sexual orientation data1
- Does schooling improve cognitive abilities at older ages?: causal evidence from nonparametric bounds1
- Does temporary disability insurance reduce older workers’ reliance on Social Security disability insurance?1
- Driving better health outcomes through integrated care systems: the role of district councils1
- During the initial COVID-19 response, HHS personnel who interacted with potentially infected passengers had limited protections1
- Dying well at home: commissioning quality end-of-life care1